Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjogren's syndrome

被引:21
|
作者
Chen, Caiqun [1 ]
Liang, Yan [2 ]
Zhang, Zhiyu [3 ]
Zhang, Zhencheng [4 ]
Yang, Zaixing [4 ]
机构
[1] Wenzhou Med Univ, Taizhou Peoples Hosp 1, Dept Chinese Pharm, Huangyan Hosp, Taizhou 318020, Zhejiang, Peoples R China
[2] Shanghai Changzheng Hosp, Dept Lab Diagnost, Shanghai 200003, Peoples R China
[3] Shanghai Changzheng Hosp, Dept Gen Practice, Shanghai 200003, Peoples R China
[4] Wenzhou Med Univ, Taizhou Peoples Hosp 1, Dept Lab Med, Huangyan Hosp, Taizhou 318020, Zhejiang, Peoples R China
关键词
YKL-40; Primary Sjogren's syndrome; Interleukin-6; Tumor necrosis factor alpha; IMMUNE-SYSTEM; CYTOKINES; PROTEIN; CELLS;
D O I
10.1016/j.intimp.2020.106878
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: There is now no single score or marker useful for evaluating disease activity of primary Sjogren's syndrome (pSS). This study was designed to explore the associations of circulating YKL-40, interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) with systemic activity and phenotypes of pSS. Methods: This study included 58 pSS patients and 30 healthy controls (HC). The sera were measured by multiplex immunoassay for YKL-40, IL-6 and TNF-alpha concentrations. The disease activity of pSS patients was evaluated by European league against rheumatism (EULAR) SS disease activity index (ESSDAI). Local severity was assessed in accordance with the Tarpley score. Results: Serum YKL-40, IL-6 and TNF-alpha levels significantly elevated in pSS patients compared with those in HC (all P < 0.001). These cytokines correlated with ESSDAI, ESR, CRP, and IgG (all P < 0.05). Serum YKL-40 level correlated markedly with age (r = 0.405, P = 0.002), neutrophil count (r = 0.399, P = 0.002) and neutrophil-to-lymphocyte ratio (NLR) (r = 0.401, P = 0.002), while IL-6 did weakly with NLR (r = 0.296, P = 0.024) and C3 (r = 0.288, 0.036). Serum levels of all three cytokines were substantially lower in patients with eye/mouth dryness vs. those without (all P < 0.05). Additionally, patients with pulmonary, renal involvement or anemia had remarkably higher concentrations of YKL-40 (all P < 0.05), while those with leukocytopenia had lower levels (P = 0.01). Fever or anemia patients showed higher serum concentrations of IL-6 (both P < 0.05), while serum levels of TNF-alpha were much higher in patients with presence of ANA, anti-SSA or anti-SSB antibodies (All P < 0.05). Serum IL-6 level correlated strongly with YKL-40 (r = 0.452, P < 0.001) and TNF-alpha (r = 0.743, P < 0.001) in pSS patients. A significant correlation was also found between YKL-40 and TNF-alpha (r = 0.308, P = 0.022). Conclusion: The circulating YKL-40, IL-6 and TNF-alpha levels increase in pSS, and all of them are significantly correlated with indicators (ESSDAI, ESR, CRP, and IgG) for systemic inflammation of pSS. Each cytokine is separately associated with specific pSS phenotype.
引用
收藏
页数:6
相关论文
共 45 条
  • [1] IL-6, but not TNF-α, increases plasma YKL-40 in human subjects
    Nielsen, Anders R.
    Plomgaard, Peter
    Krabbe, Karen S.
    Johansen, Julia S.
    Pedersen, Bente K.
    CYTOKINE, 2011, 55 (01) : 152 - 155
  • [2] Circulating levels of plasma IL-6, VEGF, YKL-40, and COMP in spondyloarthritis patients during anti-TNFα treatment
    Pedersen, Susanne Juhl
    Sorensen, Inge Juul
    Johansen, Julia Sidenius
    Madsen, Ole Rintek
    Tvede, Niels
    Hansen, Michael Sejer
    Thamsborg, Gorm
    Andersen, Lis Smedegaard
    Majgaard, Ole
    Loft, Anne Gitte
    Erlendsson, Jon
    Asmussen, Karsten
    Hansen, Annette
    Ostergaard, Mikkel
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 38 - 38
  • [3] Overexpression of YKL40,IL-6, IL-8, TNF-α in tonsils and the role of YKL40 in childhood with obstructive sleep apnea syndrome
    Wang, Ying-ge
    Lin, Chang
    Huang, Min
    Fang, Xiu-ling
    Chen, Guo-hao
    Ye, Sheng-nan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] Serum Levels of IL-17, IL-6, TNF-α and Disease Activity in Patients with Rheumatoid Arthritis
    Beyazal, M. S.
    Devrimsel, G.
    Cure, M. C.
    Turkyilmaz, A. K.
    Capkin, E.
    Karkucak, M.
    AKTUELLE RHEUMATOLOGIE, 2017, 42 (04) : 323 - 328
  • [5] Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity
    D'Auria, L
    Mussi, A
    Bonifati, C
    Mastroianni, A
    Giacalone, B
    Ameglio, F
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 1999, 12 (01) : 11 - 15
  • [6] Increased circulating levels and salivary gland expression of IL-18 in primary Sjogren's syndrome
    Bombardieri, M
    Pittoni, V
    Alessandri, C
    Conigliaro, P
    Barone, F
    Blades, MC
    Priori, R
    Pitzalis, C
    Valesini, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 64 - 65
  • [7] Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
    Sellam, Jeremie
    Proulle, Valerie
    Juengel, Astrid
    Ittah, Marc
    Richard, Corinne Miceli
    Gottenberg, Jacques-Eric
    Toti, Florence
    Benessiano, Joelle
    Gay, Steffen
    Freyssinet, Jean-Marie
    Mariette, Xavier
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (05)
  • [8] Changes in plasma IL-6, plasma VEGF and serum YKL-40 levels in patients with rheumatoid arthritis during treatment with anti-TNF-α therapy.
    Knudsen, LS
    Ostergaard, M
    Baslund, B
    Petersen, J
    Ejbjerg, B
    Szkudlarek, M
    Johansen, JS
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S378 - S378
  • [9] Faecal Levels of Calprotectin are Increased in Patients with Primary Sjogren's Syndrome and Correlates with Disease Activity
    Mandl, T.
    Ohlsson, B.
    Andreasson, K.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 81 (05) : 353 - 354
  • [10] Faecal Levels of Calprotectin Are Increased in Patients with Primary Sjogren's Syndrome and Correlates with Disease Activity
    Mandl, Thomas
    Ohlsson, Bodil
    Andreasson, Kristofer
    ARTHRITIS & RHEUMATOLOGY, 2015, 67